These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

569 related items for PubMed ID: 25212891

  • 1. Waldenström macroglobulinemia.
    Treon SP, Hunter ZR, Castillo JJ, Merlini G.
    Hematol Oncol Clin North Am; 2014 Oct; 28(5):945-70. PubMed ID: 25212891
    [Abstract] [Full Text] [Related]

  • 2. Significances of MYD88L265P and CXCR4WHIM Mutations in Waldenstrom Macroglobulinemia.
    Meng Q, Cao XX, Li J.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug 20; 39(4):578-582. PubMed ID: 28877839
    [Abstract] [Full Text] [Related]

  • 3. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease.
    Cao XX, Meng Q, Cai H, He TH, Zhang CL, Su W, Sun J, Li Y, Xu W, Zhou DB, Li J.
    Ann Hematol; 2017 Jun 20; 96(6):971-976. PubMed ID: 28280994
    [Abstract] [Full Text] [Related]

  • 4. Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemia.
    Treon SP, Cao Y, Xu L, Yang G, Liu X, Hunter ZR.
    Blood; 2014 May 01; 123(18):2791-6. PubMed ID: 24553177
    [Abstract] [Full Text] [Related]

  • 5. CXCR4 WHIM-like frameshift and nonsense mutations promote ibrutinib resistance but do not supplant MYD88(L265P) -directed survival signalling in Waldenström macroglobulinaemia cells.
    Cao Y, Hunter ZR, Liu X, Xu L, Yang G, Chen J, Tsakmaklis N, Kanan S, Castillo JJ, Treon SP.
    Br J Haematol; 2015 Mar 01; 168(5):701-7. PubMed ID: 25371371
    [Abstract] [Full Text] [Related]

  • 6. Clonal architecture of CXCR4 WHIM-like mutations in Waldenström Macroglobulinaemia.
    Xu L, Hunter ZR, Tsakmaklis N, Cao Y, Yang G, Chen J, Liu X, Kanan S, Castillo JJ, Tai YT, Zehnder JL, Brown JR, Carrasco RD, Advani R, Sabile JM, Argyropoulos K, Lia Palomba M, Morra E, Trojani A, Greco A, Tedeschi A, Varettoni M, Arcaini L, Munshi NM, Anderson KC, Treon SP.
    Br J Haematol; 2016 Mar 01; 172(5):735-44. PubMed ID: 26659815
    [Abstract] [Full Text] [Related]

  • 7. MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction.
    Xu L, Hunter ZR, Yang G, Zhou Y, Cao Y, Liu X, Morra E, Trojani A, Greco A, Arcaini L, Varettoni M, Brown JR, Tai YT, Anderson KC, Munshi NC, Patterson CJ, Manning RJ, Tripsas CK, Lindeman NI, Treon SP.
    Blood; 2013 Mar 14; 121(11):2051-8. PubMed ID: 23321251
    [Abstract] [Full Text] [Related]

  • 8. MYD88 L265P somatic mutation: its usefulness in the differential diagnosis of bone marrow involvement by B-cell lymphoproliferative disorders.
    Ondrejka SL, Lin JJ, Warden DW, Durkin L, Cook JR, Hsi ED.
    Am J Clin Pathol; 2013 Sep 14; 140(3):387-94. PubMed ID: 23955458
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characteristics of Waldenström Macroglobulinemia in Korean Patients According to Mutational Status of MYD88 and CXCR4: Analysis Using Ultra-Deep Sequencing.
    Shin DW, Kim SM, Kim JA, Park HS, Hwang SM, Im K, Kim S, Kim J, Kwon S, Yoon SS, Lee DS.
    Clin Lymphoma Myeloma Leuk; 2019 Aug 14; 19(8):e496-e505. PubMed ID: 31221512
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clone-specific MYD88 L265P and CXCR4 mutation status can provide clinical utility in suspected Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
    Burnworth B, Wang Z, Singleton TP, Bennington A, Fritschle W, Bennington R, Brodersen LE, Wells DA, Loken MR, Zehentner BK.
    Leuk Res; 2016 Dec 14; 51():41-48. PubMed ID: 27890075
    [Abstract] [Full Text] [Related]

  • 13. Detection of the MYD88L265P and CXCR4S338X mutations by cell-free DNA in Waldenström macroglobulinemia.
    Wu YY, Jia MN, Cai H, Qiu Y, Zhou DB, Li J, Cao XX.
    Ann Hematol; 2020 Aug 14; 99(8):1763-1769. PubMed ID: 32577844
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Genomics, Signaling, and Treatment of Waldenström Macroglobulinemia.
    Hunter ZR, Yang G, Xu L, Liu X, Castillo JJ, Treon SP.
    J Clin Oncol; 2017 Mar 20; 35(9):994-1001. PubMed ID: 28294689
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance.
    Varettoni M, Zibellini S, Defrancesco I, Ferretti VV, Rizzo E, Malcovati L, Gallì A, Porta MGD, Boveri E, Arcaini L, Candido C, Paulli M, Cazzola M.
    Haematologica; 2017 Dec 20; 102(12):2077-2085. PubMed ID: 28983055
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.